Juliana Santos Rosa Viegas

ORCID: 0000-0002-8615-3758
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Interference and Gene Delivery
  • Advancements in Transdermal Drug Delivery
  • 3D Printing in Biomedical Research
  • Advanced Drug Delivery Systems
  • Immunotherapy and Immune Responses
  • Dermatology and Skin Diseases
  • Cancer Cells and Metastasis
  • Silk-based biomaterials and applications
  • Cellular Mechanics and Interactions
  • Nanoparticle-Based Drug Delivery
  • Drug Solubulity and Delivery Systems
  • Nanoplatforms for cancer theranostics
  • Microscopic Colitis
  • Inflammation biomarkers and pathways
  • Nanoparticles: synthesis and applications
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Inflammatory Bowel Disease
  • S100 Proteins and Annexins
  • Skin Protection and Aging
  • Extracellular vesicles in disease
  • Sperm and Testicular Function
  • Salivary Gland Disorders and Functions
  • Hydrogels: synthesis, properties, applications
  • Polymer Nanocomposite Synthesis and Irradiation
  • Graphene and Nanomaterials Applications

Universidade de São Paulo
2009-2024

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
2023-2024

Universidade do Porto
2024

Weatherford College
2024

Centro de Investigacion Principe Felipe
2022

Universidad de Especialidades
2022

SUPERA Park of Innovation and Technology of Ribeirão Preto
2022

Universidade de Ribeirão Preto
2020-2022

Universidade Federal de Ouro Preto
2019

Universidade Federal de Minas Gerais
2017

Melanoma, the deadliest form of skin cancer, poses a significant clinical challenge for development effective treatments. Conventional in vivo animal studies have shown limited translational relevance to humans, raising strength pre-clinical models melanoma research. This review provides an in-depth analysis alternative including vitro and ex platforms such as reconstructed skin, spheroids, organoids, organotypic models, skin-on-a-chip, bioprinting. Through comprehensive analysis, specific...

10.1016/j.addr.2024.115295 article EN cc-by Advanced Drug Delivery Reviews 2024-03-24

Inflammatory bowel disease (IBD) encompasses a set of chronic inflammatory conditions, namely Crohn's and ulcerative colitis. Despite all advances in the management IBD, definitive cure is not available, largely due to lack holistic understanding its etiology pathophysiology. Several vitro, vivo, ex vivo models have been developed over past few decades order abbreviate remaining gaps. The establishment reliable predictable vitro intestinal inflammation may indeed provide valuable tools...

10.1016/j.bbadis.2024.167042 article EN cc-by Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024-01-29

Abstract The rising global prevalence of Inflammatory Bowel Disease (IBD) and its significant socio-economic impact highlight the urgent need to develop innovative solutions overcome poor targeting efficiency short retention time faced by current treatments. Hence, aim this work was use an advanced oxidative-responsive nanosystem selectively target accumulate at inflamed tissues for oral administration budesonide, a corticosteroid used treat intestinal inflammation. For system,...

10.1093/ibd/izae282.013 article EN Inflammatory Bowel Diseases 2025-02-01

We report an enhanced X-ray shielding effect related to graphene. The mass attenuation coefficients measured for nanocomposites made of poly(vinylidene fluoride) (PVDF) filled with 1.88 wt % functionalized graphene oxides (GO), pyrolytic graphite (PG), multiwalled carbon nanotubes (MWCNT), and amorphous (soot) have been compared. For 6.9 keV photons, the value graphene-based nanocomposite was found be four times higher than that encountered other graphitic-based nanocomposites. were photons...

10.1021/acs.iecr.7b02711 article EN Industrial & Engineering Chemistry Research 2017-09-28

We developed poly-ε-caprolactone (PCL)-based nanoparticles containing D-α-tocopherol polyethylene glycol-1000 succinate (TPGS) or Poloxamer 407 as stabilizers to efficiently encapsulate genistein (GN). Two formulations, referred PNTPGS and PNPol, were prepared using nanoprecipitation. They characterized by size PDI distribution, zeta potential, nanoparticle tracking analysis (NTA), GN association (AE%), infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC). PNTPGS-GN...

10.1590/s2175-97902024e22542 article EN cc-by Brazilian Journal of Pharmaceutical Sciences 2024-01-01

Abstract Inflammatory Bowel Disease (IBD) is a chronic inflammatory condition affecting the gastrointestinal tract (GIT). Glucagon‐like peptide‐2 (GLP‐2) analogs possess high potential in treatment of IBD by enhancing intestinal repair and attenuating inflammation. Due to enzymatic degradation poor absorption, GLP‐2 are administered parenterally, which leads patient compliance. This work aims develop IBD‐targeted nanoparticles (NPs) for oral delivery analog, Teduglutide (TED). Leveraging...

10.1002/smll.202402502 article EN Small 2024-07-15

The physicochemical characteristics of nanostructured suspensions are important prerequisites for the success new drug development. This work aimed to develop nanometric systems containing Cymbopogon densiflorus leaf essential oil and evaluate their antimicrobial activity. was isolated by hydrodistillation from leaves analyzed GC-MS. main constituents were found be trans-p-mentha-2,8-dien-1-ol, cis-p-mentha-2,8-dien-1-ol, trans-p-mentha-1(7),8-dien-2-ol, cis-piperitol,...

10.1021/acs.jnatprod.8b00870 article EN Journal of Natural Products 2019-12-09

The oral administration of the glucagon-like peptide-1 analogue, semaglutide, remains a hurdle due to its limited bioavailability. Herein, neonatal Fc receptor (FcRn)-targeted nanoparticles (NPs) were designed enhance delivery semaglutide. nanocarriers covalently linked FcRn-binding peptide FcBP or affibody molecule Z

10.1021/acsnano.4c11172 article EN ACS Nano 2024-10-02

The stratum corneum (SC) is the skin's outermost layer, organized by clusters of corneocytes among a lipid matrix, acting as barrier. This "brick and mortar" organization modified in many skin diseases. We proposed lesioned-skin model for assessing permeability topical formulations impact integrity on molecules. anticipate that removal SC compromises barrier function, making it more permeable, affecting biopharmaceutics formulations. By stripping with 25 strips (Corneofix®), thickness was...

10.1016/j.biopha.2023.115841 article EN cc-by Biomedicine & Pharmacotherapy 2023-11-07

Abstract In vitro models are crucial in cancer research, but they must truthfully mimic vivo tumors for clinical relevance. The development of unprecedent melanoma quadruple multicellular tumoroids (MCTs) is proposed comprising tumor cells, keratinocytes, fibroblasts, and monocytes that replicate architecture, microenvironment, secretome behavior. These MCTs 300 µm diameter secreted keratin collagen, showing complexity proportional to their cell combinations. Further, closely resembled terms...

10.1002/advs.202408707 article EN cc-by Advanced Science 2024-10-30
Coming Soon ...